Clinical

Dataset Information

0

PK/PD Investigation of Modufolin (Arfolitixorin) in Plasma, Tumor and Adjacent Mucosa Adjacent Mucosa in Patients With Colon Cancer


ABSTRACT: The purpose of this study is to compare the concentration of four different metabolites in the tumor, in adjacent mucosa and in plasma in patients with colon cancer receiving two different doses of Modufolin (arfolitixorin) and Levoleucovorin (Isovorin), respectively (60 and 200 mg/m2).

DISEASE(S): Rectal Neoplasms,Colon Cancer,Colorectal Neoplasms,Neoplasms,Colonic Neoplasms

PROVIDER: 2131633 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

2014-09-03 | E-MTAB-1338 | biostudies-arrayexpress
2014-08-13 | E-GEOD-42690 | biostudies-arrayexpress
| PRJNA622329 | ENA
| PRJNA299032 | ENA
| PRJNA37447 | ENA
2017-01-23 | PXD005106 | Pride
| EGAS00001005303 | EGA
2017-02-15 | GSE94882 | GEO
2017-02-15 | GSE94881 | GEO
2024-07-24 | E-MTAB-13624 | biostudies-arrayexpress